China Pharma (NYSE:CPHI) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHIFree Report) in a research report report published on Tuesday morning. The firm issued a hold rating on the stock.

China Pharma Trading Up 5.0 %

China Pharma stock opened at $0.19 on Tuesday. China Pharma has a fifty-two week low of $0.13 and a fifty-two week high of $0.69. The firm’s fifty day moving average price is $0.21 and its 200-day moving average price is $0.22. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.26 and a current ratio of 0.79.

China Pharma Company Profile

(Get Free Report)

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

Further Reading

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.